Basic Information
ATKC is a leading enterprise in China specializing in the research and development of tumor electric field therapy technology. In recent years, it has been committed to developing personalized tumor electric field therapy systems suitable for Chinese patients. With the full collaboration and strong support of multidisciplinary expert teams, including domestic professional medical associations and their clinical experts, electronic engineering, material science, and imaging medicine, the founding team has carried out independent product research and development focusing on electric field therapy technology. Currently, the finalized product has entered the clinical trial stage.
Hunan Antai Kangcheng Biotechnology Co., Ltd.
Hunan,China
15~50 people
May 03, 2017
ad@atkc.com.cn

